杂志简称：cancer discov
中文译名：《癌症发现》
收录属性：高质量科技期刊（t1）, scie（2024版）, 目次收录（维普）,英文期刊,
自引率：1.70%
投稿方向：医学、oncology 肿瘤学
SCI/E期刊基本信息
出版周期：月刊 地区：美国
中科院分区：1区
是否TOP：TOP期刊
是否综述：非综述期刊
是否OA：非OA期刊
国际标准刊号：ISSN 2159-8274；EISSN2159-8290
杂志语言：英语
出版国家：美国
杂志官网 联系方式
出版地址：615 CHESTNUT ST,17TH FLOOR,PHILADELPHIA,USA,PA,19106-4404
杂志邮箱：
传真：(267) 646-0590
投稿网址：http://cd.msubmit.net/
杂志官方网址：https://cancerdiscovery.aacrjournals.org/
出版商网址：http://www.aacr.org
杂志投稿要求
投稿须知【杂志社官方网站信息】
About Cancer Discovery
Scope
Cancer Discovery publishes high-impact, peer-reviewed articles describing major advances in research and clinical trials. As the premier cancer information resource, the Journal also presents Review Articles, Perspectives and Commentaries, News stories, and Research Watch summaries of important journal articles to its readers to keep them informed about the latest findings in the field. Topics span the spectrum of cancer research and medicine from the laboratory to the clinic and epidemiologic studies.
Manuscript Submission
Cancer Discovery welcomes submission of original research and review articles to the journal. For descriptions and length requirements of the article types available to submitting authors, see the journal’s Categories of Articles.
The AACR Journals all use a similar Editorial Process and adhere to the same overarching Editorial Policies, both of which are detailed in the Instructions for Authors. These instructions contain important guidelines on authorship, publishing ethics, availability of materials and data, and data analysis and reporting. Authors should be familiar with these instructions prior to submitting their work to the journal.
Manuscripts are stringently reviewed for high standards of scientific merit, and only those articles that report results of novel, timely, and broadly significant research are accepted for publication.
Categories of Articles
Scope
Cancer Discovery publishes high-impact, peer-reviewed articles describing major advances in research and clinical trials. As the premier cancer information resource, the Journal also presents Review Articles, Perspectives and Commentaries, News stories, and Research Watch summaries of important journal articles to its readers to keep them informed about the latest findings in the field. Topics span the spectrum of cancer research and medicine from the laboratory to the clinic and epidemiologic studies.
In addition to reviewing the below guidelines, please consult the general AACR Journals' Instructions for Authors prior to submission.
Categories of Articles
The following types of articles will be considered for publication in the journal. Note that word counts for all article types are exclusive of references, tables, and figure legends. Authors are advised that submissions not adhering to the guidelines provided both in the general AACR Journals' Instructions for Authors and below may be returned prior to the commencement of the course of consideration.
Research Articles
Research Articles report on original studies with broad impact across the fields of basic, translational, clinical, and epidemiologic cancer research as well as cancer prevention research. These articles should be of exceptional significance to a diverse audience of cancer researchers and scientists.
150-word abstract
50-word statement of significance
6,000 words of text
50 references
7 figures and/or tables total (no panel limit; each figure or table must fit on a single printed page)
Sections should be arranged in the following order: title page, abstract, statement of significance, introduction, results, discussion, methods, references, tables, table legends, figure legends, and figures
Results and Discussion sections must not be combined
Research Briefs
Research Briefs may report on early clinical data or discovery-based studies that are not sufficiently developed for publication as Research Articles but have the potential to make a significant impact on research areas and/or patient care.
150-word abstract
50-word statement of significance
3,500 words of text
25 references
4 figures and/or tables total (no panel limit; each figure or table must fit on a single printed page)
Sections should be arranged in the following order: title page, abstract, statement of significance, introduction, results, discussion, methods, references, tables, table legends, figure legends, and figures
Results and Discussion sections must not be combined
Reviews
Review Articles provide authoritative, comprehensive overviews of timely subjects geared toward the general cancer research community. These articles should include the author's point of view on how the subject relates to the current state of the field and how it could affect research and/or patient care.
100 word abstract
three-to four-sentence statement of significance
7,000 words of text
75 references
6 figures and/or tables total (no panel limit; each figure or table must fit on a single printed page)
Mini Reviews
Mini Reviews are authoritative, comprehensive overviews on timely subjects. Subjects covered in Mini Reviews are narrower, either in scope or depth, than those covered in full-length Review Articles and include the author's perspective on how the subject relates to the current state of the field and how it could impact research/treatment.
100-word abstract
one-to two-sentence statement of significance
4,000 words of text
50 references
3 figures and/or tables total (no panel limit; each figure or table must fit on a single printed page)
Letters to the Editor
Letters to the Editor express views related to published articles that do not in themselves constitute original research. Letters to the Editor must focus on and refer to an article published in Cancer Discovery within the previous 3 months. If found to meet the journal's publication criteria (i.e., if it comprises scholarly commentary on a subject of importance and interest to a broad readership), the Letter may be sent to various pertinent parties, including the author(s) of the cited article and possibly to other interested experts in the field, in order to grant them the opportunity to respond. Any such response would be vetted similarly and published in the same issue of the journal as the Letter.
The title should read as “‘Running title of the original article’ — Letter”; please note that the Editors-in-Chief reserve the right to modify the title
500 words of text
5 references; the first reference must cite the originating article
Figures or tables are permitted only if they show data that refute the conclusions of the originating article; figures or tables featuring unpublished data in support of the conclusions of the originating article will not be considered